Committee Votes Against Accepting Modafinil for ADHD
The FDA’s Psychopharmacologic Drugs Advisory Committee has voted not to recommend approval of modafinil tablets (Sparlon, Cephalon), an investi-gational medication for children and adolescents with ADHD. Cephalon had received an approvable letter from the FDA in October 2005. Modafinil was deemed effective for its intended use, but more safety data were needed. Sparlon is a [...]
Read User's Comments